Corneal Endothelial Cell Transplant Market worth USD 856.18 million by 2033

The Market Statsville Group (MSG) publishes the new report on the "Corneal Endothelial Cell Transplant Market By Technique, By Indication, By End-User (Eye Clinics, Ambulatory Surgical Centers, Others), By Region – Global Share and Forecast to 2033

According to the Market Statsville Group (MSG), the global corneal endothelial cell transplant market size is expected to grow from USD 446.37 million in 2022 to USD 856.18 million by 2033, at a CAGR of 6.10% from 2023 to 2033.

The corneal endothelial cell transplant market consists of sales of corneal endothelial cell transplant services by entities (organizations, sole traders, and partnerships). In EK, a new method of corneal transplantation, a healthy new endothelium is transplanted on a thin layer of donor corneal tissue which is floated into place and adheres without sutures. The eye wall is left intact. This helps to preserve a normal corneal shape, normal strength and a normal focusing power for the eye. In recent years, the prevalence of ocular illnesses such as cataract and glaucoma has increased dramatically. Such an increase in ophthalmic diseases has created high need for effective diagnosis to design perfect treatment and correction. This is expected to propel growth of the artificial cornea and corneal endothelial cell transplant market. Moreover, surge in government initiatives to control visual impairment also boost the market growth over the forecast period. On the other hand, Technological advancements in ophthalmic lasers, such as development of femtosecond lasers, have reduced surgery time and improved procedural outcomes and convenience. However, high cost of these instruments is expected to restrain their growth. Whereas, increase in the technological advancements in the field of cornea will create huge opportunities for the new player and existing player to grow in the market over the period.

Global Corneal Endothelial Cell Transplant Market Segmentation

The overall corneal endothelial cell transplant market has been segmented into technique, indication, end user, and region.

• By Technique (Descemet Membrane Endothelial Keratoplasty (DMEK), Deep Lamellar Endothelial Keratoplasty (DLEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Pre-Descemet Endothelial Keratoplasty (PDEK), Descemetorhexis Without Endothelial Keratoplasty (DWEK), Descemet Stripping Only (DSO) And Descemet Membrane Endothelial Transfer (DMET))
• By Indication Type (Fuchs dystrophy, Fungal Corneal Ulcer, Keratoconus, Keratitis, Acquired Pseudophakic, Bullous keratopathy, Iridocorneal endothelial syndrome, Corneal Stromal Dystrophies, Postinfective Keratitis, Other Indications)
• By End Users (Eye Clinics, Ambulatory Surgical Centers, Others)
• By Region (US, Canada, Mexico, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Southeast Asia, Australia, Saudi Arabia, UAE, South Africa, Qatar, Nigeria, Israel, Brazil, Argentina, Peru)

Pre-Descemet Endothelial Keratoplasty (PDEK) segment is at the highest CAGR during the forecast period

Pre-Descemet Endothelial Keratoplasty (PDEK) segment is expected to grow at the highest CAGR during the forthcoming period due to the graft that allows easy intraoperative handling, as it is not as flimsy as Descemet’s membrane alone, and PDEK can use donor eyes of any age. Pre Descemet's endothelial keratoplasty (PDEK) is a kind of endothelial keratoplasty in which the PDL, Descemet's membrane (DM), and endothelium are transplanted. Traditionally, surgeons utilise a complete cornea or sections of the five layers of the cornea to undertake corneal transplantation surgery.

Don't miss out on business opportunities in Corneal Endothelial Cell Transplant Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

The Asia Pacific to account for the highest CAGR during the forecast period

Over the forecast period, the Asia Pacific market is expected to grow rapidly. Healthcare products and services are becoming more popular due to increasing healthcare infrastructure and in-hospital healthcare facilities.

Due to the growing elderly population and the increasing number of people determined to fight diseases such as heart disease, diabetes, and various eyes disease, the Asia Pacific corneal endothelial cell transplant market is growing at a promising CAGR. Furthermore, Asia-Pacific corneal endothelial cell transplant devices are still in their infancy. These factors drove corneal endothelial cell transplant during the review period and will continue to support market growth in the future. Furthermore, rising government spending on healthcare in various countries is a major driver of the region's corneal endothelial cell transplant market growth.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the corneal endothelial cell transplant market. It also consists of the profiles of leading companies such as  Ajl Ophthalmic SA, Keramed Inc, CorneaGen, Corneat Vision, Aurion, Emmecell, Cornea Biosciences, Kowa Company, Trefoil Therapeutics. The key players' growing research and development activities for launching innovative healthcare devices with advanced features and strategic unions are expected to drive market growth.

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

800 Third Avenue Suite A #1519

New York, US 10022

USA: +1 646-663-5829 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com